• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Neoadjuvant Osimertinib With or Without Chemotherapy Improves Response in Resectable EGFRm NSCLC

by MM360 Staff | Jun 4, 2025 | Myeloma News

Source: Pharmacy Times articles Results from the NeoADAURA trial demonstrate the sustained efficacy of osimertinib in patients with epidermal growth factor receptor-mutated (EGFRm) non-small-cell lung cancer (NSCLC). Read More

Continuing Novel Therapeutic Research Presents New Options in Lung Cancer

by MM360 Staff | Jun 4, 2025 | Uncategorized

Source: CureToday articles Dr. Jared Weiss details the importance of continued research into novel therapies for patients with lung cancer. Read More

Fixed-Duration Ibrutinib Plus Venetoclax Shows Long-Term Efficacy in First-Line CLL/SLL Treatment

by MM360 Staff | Jun 4, 2025 | Myeloma News

Source: Pharmacy Times articles Ibrutinib plus venetoclax shows promising long-term survival rates, including those who are considered high risk. Read More

GLP-1 Receptor Agonists and FGF21 Analogs May Be Key Treatments for MASH-Related Cirrhosis

by MM360 Staff | Jun 4, 2025 | Myeloma News

Source: Pharmacy Times articles New treatments for metabolic dysfunction-associated steatohepatitis (MASH)–related cirrhosis address unique challenges in drug development. Read More

Dealing with Insensitivity After Breast Cancer Surgery

by MM360 Staff | Jun 4, 2025 | Uncategorized

Source: CureToday articles Breast cancer surgery can disfigure the body in some way, and often the scars are more than skin deep, which may worsen by the actions of others. Read More
« Older Entries
Next Entries »

Recent Content

  • Ambulatory Pharmacy in Action: House Calls and Harm Reduction Clinics Expand the Reach of Care
  • Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer
  • Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
  • Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
  • Targeted Chemo Improves Survival in Early-Stage Lung Cancer
  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT